Internal Medicine, Medical Oncology · Owensboro, KY
NPI
1366431017
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1000 Breckenridge St Ste 201
Owensboro, KY, 42303
Phone (270) 688-3445
Groups this clinician bills Medicare through
Medicare paid, 2024
$266K
3,406 services
Medicare patients, 2024
1,009
Average age 74
Drug cost, 2024
$7.4M
4,341 prescriptions
Company payments, 2025
$4,272
From 46 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jewraj G Maheshwari was code 99214 (office e&m - established), 2,211 times for 769 patients. In total Jewraj G Maheshwari billed 3,406 services in 33 codes, and Medicare paid $266K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,211 | 769 | $80.69 | $178K |
| 99214 Office E&M - Established | Facility | 275 | 112 | $67.94 | $19K |
| 99215 Office E&M - Established | Office | 160 | 112 | $128.36 | $21K |
| 99213 Office E&M - Established | Office | 96 | 88 | $54.13 | $5,197 |
| 99204 Office E&M - New | Office | 90 | 90 | $117.96 | $11K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 69 | 13 | $0.93 | $64.05 |
| 96372 Injection Administration | Office | 69 | 13 | $10.07 | $695 |
| 99213 Office E&M - Established | Facility | 62 | 51 | $43.36 | $2,688 |
| 99222 Hospital E&M - Initial | Facility | 56 | 52 | $98.99 | $5,543 |
| 99231 Hospital E&M - Subsequent | Facility | 45 | 26 | $36.49 | $1,642 |
| 99205 Office E&M - New | Office | 44 | 44 | $159.22 | $7,006 |
| 99232 Hospital E&M - Subsequent | Facility | 31 | 20 | $58.75 | $1,821 |
| 99204 Office E&M - New | Facility | 26 | 26 | $97.39 | $2,532 |
| 99223 Hospital E&M - Initial | Facility | 24 | 20 | $128.49 | $3,084 |
| 36415 Venipuncture Blood Collection | Office | 23 | 18 | $8.65 | $199 |
By year: 2022 $278K for 3,635 services; 2023 $261K for 3,451 services; 2024 $266K for 3,406 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 23 | 18 | $8.65 | $199 |
Medicare prescription drug claims, 2024
In 2024, the drug Jewraj G Maheshwari prescribed most often to Medicare patients was Anastrozole, with 339 prescriptions and refills. In total Jewraj G Maheshwari wrote 4,341 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 339 | 631 | 72 | $4,558 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 338 | 338 | 81 | $6,156 |
| Ondansetron Odt Ondansetron | 312 | 314 | 143 | $4,839 |
| Prochlorperazine Maleate Generic | 304 | 305 | 135 | $4,598 |
| Letrozole Generic | 281 | 608 | 65 | $4,699 |
| Dexamethasone Generic | 143 | 157 | 44 | $1,942 |
| Tamoxifen Citrate Generic | 141 | 301 | 30 | $3,147 |
| Alprazolam Generic | 127 | 127 | 31 | $799 |
| Hydroxyurea Generic | 110 | 193 | 23 | $2,721 |
| Fentanyl Generic | 107 | 107 | 23 | $15K |
| Acyclovir Generic | 102 | 164 | 23 | $1,544 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 94 | 94 | 25 | $1,415 |
| Exemestane Generic | 92 | 141 | 21 | $13K |
| Eliquis Apixaban | 85 | 116 | 18 | $64K |
| Oxycodone Hcl Generic | 84 | 85 | 24 | $2,484 |
Brand drugs: 635 claims; generic drugs: 3,706 claims; opioid claims: 658.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jewraj G Maheshwari $4,272 ($4,272 in general payments such as food, travel and fees) from 46 companies. The largest payer was Novartis Pharmaceuticals Corporation with $481.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 32 | $481 |
| Daiichi Sankyo Inc. 4568.T | 19 | $466 |
| Janssen Biotech, Inc. JNJ | 14 | $437 |
| Pfizer Inc. PFE | 17 | $311 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $269 |
| Gilead Sciences, Inc. GILD | 12 | $214 |
| Abbvie Inc. ABBV | 14 | $201 |
| Merck Sharp & Dohme LLC MRK | 11 | $200 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $153 |
| Astellas Pharma US Inc 4503.T | 10 | $152 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.